Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QX027N
- Development stage
- Phase 2
- Lead developer
- Qyuns Therapeutics
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Subcutaneous
01
Overview
QX027N is a long-acting bispecific monoclonal antibody that targets both human thymic stromal lymphopoietin (TSLP) and human interleukin-13 (IL-13).[6][9] The drug has been engineered with an extended half-life to enable less frequent dosing compared to existing biologics.[6] Through dual, long-acting inhibition of these well-validated inflammatory targets, QX027N is designed to provide deeper and more durable disease control in respiratory and dermatological conditions.[6][9] Developed by Qyuns Therapeutics, it represents a significant advancement in the company's bispecific antibody pipeline for autoimmune and allergic diseases.[3]
- Brand names
- WIN027WIN-027WIN 027
02
Targets
IL-13 (Interleukin-13)TSLP (Thymic stromal lymphopoietin)
Beyond the preview
Go deeper on QX027N.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QX027N.